Literature DB >> 7806784

Early surgery for epilepsy: redefining candidacy.

T J Resnick1, M Duchowny, P Jayakar.   

Abstract

Surgical resection for localization-related epilepsy has recently become a generally accepted treatment in children. Evidence of the poor outcome in natural history studies of temporal lobe epilepsy in childhood initiated consideration of surgical intervention. Subsequent favorable outcome following surgery was encouraging. A number of variables differentiate adults with focal seizures from children. Evolving biologic factors modify the clinical and electroencephalographic expression of seizures in childhood. The pathologic substrate is different, and there is a higher incidence of extratemporal epilepsy. Chronic seizures beginning under age 2 years rarely remit, especially when associated with a demonstrable structural lesion. Behavioral consequences of chronic seizures are significant and become a major problem by adolescence if seizures are not controlled. Early surgery results in superior functional outcome, although subtle deficits persist postoperatively. Surgical outcome is as favorable as in adults with improvements in behavioral status and socialization. Abundant data exist to more adequately assess the benefits and risks of surgery in children so that intervention is not deferred longer than it needs to be.

Entities:  

Mesh:

Year:  1994        PMID: 7806784

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Comparison of temporal lobectomies of children and adults with intractable temporal lobe epilepsy.

Authors:  Yun Jin Lee; Hoon-Chul Kang; Sun Joon Bae; Heung Dong Kim; Jeong Tae Kim; Byung In Lee; Kyoung Heo; Jin Woo Jang; Dong Seok Kim; Tae Seung Kim; Joon Soo Lee
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

Review 2.  Present status of surgical intervention for children with intractable seizures.

Authors:  Dewi T Depositario-Cabacar; James J Riviello; Masanori Takeoka
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.